CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $44,000 | 0.0% | 54,063 | 0.0% | 0.00% | – |
Q4 2021 | $44,000 | -32.3% | 54,063 | 0.0% | 0.00% | – |
Q3 2021 | $65,000 | -89.7% | 54,063 | -86.7% | 0.00% | – |
Q2 2021 | $629,000 | -48.3% | 405,290 | -20.0% | 0.00% | – |
Q1 2021 | $1,217,000 | -14.1% | 506,726 | +5.5% | 0.00% | -100.0% |
Q4 2020 | $1,417,000 | +96.3% | 480,106 | +1.7% | 0.00% | – |
Q3 2020 | $722,000 | -13.7% | 471,893 | +40.9% | 0.00% | – |
Q2 2020 | $837,000 | +34.6% | 334,796 | +9.8% | 0.00% | – |
Q1 2020 | $622,000 | -33.0% | 304,894 | +1.4% | 0.00% | – |
Q4 2019 | $929,000 | +1.6% | 300,542 | +9.9% | 0.00% | -100.0% |
Q3 2019 | $914,000 | -8.9% | 273,569 | -12.7% | 0.00% | 0.0% |
Q2 2019 | $1,003,000 | +37.6% | 313,252 | +23.4% | 0.00% | – |
Q1 2019 | $729,000 | -33.7% | 253,751 | -7.2% | 0.00% | -100.0% |
Q4 2018 | $1,100,000 | -14.9% | 273,396 | -1.2% | 0.00% | 0.0% |
Q3 2018 | $1,293,000 | +51.1% | 276,711 | +166.2% | 0.00% | 0.0% |
Q2 2018 | $856,000 | – | 103,961 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |